Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Insuvia provides global pharmacovigilance and regulatory affairs services to biopharmaceutical companies. It specializes in supporting the safety and compliance needs of companies developing biological products such as mAbs, cell/gene therapies, vaccines, and biosimilars. The company acts as an external pharmacovigilance/regulatory unit for clients lacking internal infrastructure or seeking to focus on commercial activities. With deep expertise in local regulations across Europe, Eurasia & CIS, MENA, Asia Pacific, and Latin America regions—and a client base that includes many biotech firms—Insuvia ensures product safety from clinical development through post-marketing phases. The company does not develop its own drugs but supports client programs at all stages of the product lifecycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Insuvia.